Follow us
EN
EN

One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

All news

Archive

✕
14 February 2017
7913
Study: migrants start HIV treatment later

Study: migrants start HIV treatment later

According to a study of over 150,000 people living with HIV in western Europe, migrants from other parts of the world tend to start cART (combination antiretroviral treatment) later than those born in western Europe.
14 February 2017
9264
Ghana to produce ART drugs locally

Ghana to produce ART drugs locally

Ghana's government has committed to support local pharmaceutical companies to manufacture anti-retroviral drugs for persons living with HIV and AIDS. During a visit from the Executive Director of the Joint United Nations Programme on HIV and AIDS (UNAIDS), Michael Sidibe, ...
14 February 2017
8277
NHS introduces postcode lottery, new restrictions on IVF

NHS introduces postcode lottery, new restrictions on IVF

Great Britain's cash-strapped NHS has introduced a postcode lottery for IVF, along with new limitations on who can receive the treatment. The restrictions vary by region, but many allow the treatment only in “exceptional” circumstances, for instance when a man could infect ...
13 February 2017
8097
New Zealand: Government to fund PrEP

New Zealand: Government to fund PrEP

The New Zealand Labour party made a pledge to fund a pre-exposure prophylaxis medication (PrEP) that reduces the risk of acquiring HIV by more than 90 percent. The once-a-day pill regimen is designed for people who are HIV-negative, and, according to major studies, if taken ...
13 February 2017
7482
More PrEP awareness needed for transgender women

More PrEP awareness needed for transgender women

The Journal of Adolescent Health has published a new study regarding the awareness of HIV pre-exposure prophylaxis (PrEP) among young transgender women (YTW). The study was performed by a group of scientists from the University Of Pennsylvania Perelman School Of Medicine, ...
13 February 2017
7084
Study: High HCV reinfection rate among MSM in Europe

Study: High HCV reinfection rate among MSM in Europe

An analysis of HCV reinfection incidence rates in HIV-positive men who have sex with men in Western Europe was published in the February issue of the Journal of Hepatology. The team of researchers has analyzed data on HIV positive men who have sex with men (MSM) between ...
10 February 2017
7290
Thailand has eliminated mother-to-child transmission of HIV

Thailand has eliminated mother-to-child transmission of HIV

Due to strong political leadership and dramatically increased investment, Thailand has reached a huge success in the fight against HIV in recent years. According to a study published in Paediatrics and International Child Health reports, the country has become the first ...
9 February 2017
7328
Legalization of sex work helps to reduce the prevalence of HIV in Europe

Legalization of sex work helps to reduce the prevalence of HIV in Europe

According to a recent analysis of legislation, criminalization of all aspects of sex work leads to higher prevalence of HIV among sex workers living with HIV compared to countries that have legalized some aspects of sex work. Data for the analysis came from 27 countries ...
9 February 2017
7584
Risky sex behavior is on the rise among MSM

Risky sex behavior is on the rise among MSM

Condomless sex and other risky sex behaviors are on the rise among men who have sex with men in the United States. Scientists from the University of Connecticut analyzed data from surveys conducted in 1997, 2005,2006, and 2015 at the Atlanta Gay Pride Festival. The results ...
8 February 2017
7681
Study: Poor adherence to ARV among women compared to men

Study: Poor adherence to ARV among women compared to men

A group of researchers from Canada published the results of their study on adherence to ART medications in the journal HIV Medicine. According to the study, women are more likely to have problems with adherence compared to men.
We use cookies on this site to enhance your experience.
By clicking any button on this website you are giving your consent for us to set cookies.